Metraipolis › archive › dc_749b397d34d9

Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update — Europe PMC PMID:42150996

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42150996
DOI
10.1016/j.clinthera.2026.04.021
License (as archived)
solo-consultazione
Archived
2026-11-02T04:59:41.107Z
SHA-256 of the archived text
6f2ac60803095f601f4023efc9e874d2e0fabea5fb52870eda7e4143ee989ee1
Stable URL of this page
https://metraipolis.com/documento/dc_749b397d34d9

How to cite

Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update — Europe PMC PMID:42150996 — Europe PMC (en), https://europepmc.org/article/MED/42150996 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_749b397d34d9 (Metraipolis archive dc_749b397d34d9, sha256 6f2ac60803095f601f4023efc9e874d2e0fabea5fb52870eda7e4143ee989ee1)
BibTeX
@misc{dc749b397d34d9,
  title = {Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update — Europe PMC PMID:42150996},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42150996},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_749b397d34d9; sha256 6f2ac60803095f601f4023efc9e874d2e0fabea5fb52870eda7e4143ee989ee1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42150996. Agents can read the archived copy with the MCP tool read_document.